These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17425678)

  • 1. Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix.
    Tong SY; Lee YS; Park JS; Namkoong SE
    Int J Gynecol Cancer; 2007; 17(6):1307-13. PubMed ID: 17425678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus-31-related types predict better survival in cervical carcinoma.
    Huang LW; Chao SL; Hwang JL
    Cancer; 2004 Jan; 100(2):327-34. PubMed ID: 14716768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
    Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
    Int J Gynecol Cancer; 2001; 11(1):39-48. PubMed ID: 11285032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
    Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
    J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus genotype as a major determinant of the course of cervical cancer.
    Lombard I; Vincent-Salomon A; Validire P; Zafrani B; de la Rochefordière A; Clough K; Favre M; Pouillart P; Sastre-Garau X
    J Clin Oncol; 1998 Aug; 16(8):2613-9. PubMed ID: 9704710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.
    Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
    Zentralbl Gynakol; 2001 Feb; 123(2):91-101. PubMed ID: 11265139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical small cell carcinoma frequently presented in multiple high risk HPV infection and often associated with other type of epithelial tumors.
    Li P; Ma J; Zhang X; Guo Y; Liu Y; Li X; Zhao D; Wang Z
    Diagn Pathol; 2018 May; 13(1):31. PubMed ID: 29788963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases.
    Kasamatsu E; Cubilla AL; Alemany L; Chaux A; Tous S; Mendoza L; Paez M; Klaustermeier JE; Quint W; Lloveras B; de Sanjose S; Muñoz N; Bosch FX
    J Med Virol; 2012 Oct; 84(10):1628-35. PubMed ID: 22930512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
    Baser E; Can F; Unlukaplan M; Ayhan A
    Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.
    Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD
    Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
    Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
    J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevaccination distribution of human papillomavirus types in Italian women with high-risk lesions and cervical neoplasia.
    De Francesco MA; Gargiulo F; Schreiber C; Ciravolo G; Salinaro F; Manca N
    Intervirology; 2010; 53(6):417-25. PubMed ID: 20606464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical status and expression of HPV genes in cervical cancers.
    Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
    Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34.
    Michimata R; Watari H; Tomaru U; Sakuragi N; Ishizu A
    Pathobiology; 2013; 80(5):259-64. PubMed ID: 23689419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV-DNA, vascular space invasion, and their impact on the clinical outcome in early-stage cervical carcinomas.
    Graflund M; Sorbe B; Sigurdardóttir S; Karlsson M
    Int J Gynecol Cancer; 2004; 14(5):896-902. PubMed ID: 15361201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype.
    de Cremoux P; de la Rochefordière A; Savignoni A; Kirova Y; Alran S; Fourchotte V; Plancher C; Thioux M; Salmon RJ; Cottu P; Mignot L; Sastre-Garau X
    Int J Cancer; 2009 Feb; 124(4):778-82. PubMed ID: 19035459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
    Cheah PL; Looi LM; Ng MH; Sivanesaratnam V
    J Clin Pathol; 2002 Jan; 55(1):22-6. PubMed ID: 11825919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment.
    Lindel K; Burri P; Studer HU; Altermatt HJ; Greiner RH; Gruber G
    Int J Gynecol Cancer; 2005; 15(2):278-84. PubMed ID: 15823112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.